PHILADELPHIA, June 17, 2025 /PRNewswire/ -- Researchers at Children's Hospital of Philadelphia (CHOP) reported long-term clinical outcomes for the largest single center cohort of individuals who ...
MIAMI, Oct. 27, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (LGVN) (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that its positive long-term ...
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHS Full enrollment achieved for pivotal Phase 2b clinical ...
A rare double organ transplant, the first of its kind at Children’s Hospital Colorado, is giving a brave 11-year-old girl a ...
MIAMI, June 24, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic ...
An 11-year-old girl in Colorado is now able to live a healthier life after the Children’s Hospital Colorado in Aurora was ...
In a rare and historic achievement, Children’s Hospital Colorado successfully completed its first dual heart and liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback